drugset / Trial / NCT00945945

A Study of Duloxetine in Patients With Osteoarthritis Knee Pain

NCT00945945

Phase 3 Completed 424 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to determine if duloxetine 60 mg once daily (QD) reduces pain severity in patients with osteoarthritis (OA) knee pain compared with placebo.

Timeline

Start
2009-07
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications